David Tepper’s Appaloosa Management Cuts $CVI $GT, Raises $AAPL

David Tepper is the founder of Appaloosa Management. He has become one of the world’s richest men by betting on distressed stocks (read more about David Tepper) – something he does very well. Tepper has a strong track record for spotting stocks with a lot of upside potential and the means to make it happen, making him one of the hedge fund managers we pay careful attention to.

David Tepper

Appaloosa Management’s 13F portfolio shrunk in size considerably from the end of the third quarter, when it had 50 positions collectively valued at $1.54 billion. According to a 13F filed with the SEC on February 14, Appaloosa Management had just 29 holdings, with a total value of $764.82 million, at the end of the fourth quarter. The largest of these positions was a $93.74 million holding in CVR Energy (CVI). Appaloosa had over 5.00 million shares in the company at the end of the fourth quarter. As significant as the position was at the end of December, it is significantly smaller than it was at the end of the third quarter, when Appaloosa held 6.31 million shares in the company, with a total value of $133.38 million.

CVR Energy opened trading on February 15 at $27.93 a share on a mean one-year target estimate of $30.50 a share (range $27 to $35). The upside may be conservative, but the stock is priced low at 8.31 times its forward earnings. CVR Energy is also priced low relative to its peers. Take HollyFrontier Corp (HFC) for instance. It is priced in the same ballpark, at 7.94 times its forward earnings but it has much less upside. HollyFrontier opened at $34.44 with a mean one-year target estimate of $34.92. Another positive about CVR Energy is hedge fund interest. Carl Icahn offered to buy the company for $30 per share this week. Icahn’s involvement doesn’t necessarily mean that the stock will be sold at a large premium though. His track record is mixed on this front. Last year he made a similar offer for Clorox and unsuccessfully tried to entice other buyers to bid for the company.

David Tepper was also bullish on Goodyear Tire & Rubber Co (GT). His Appaloosa Management had 6.06 million shares in the company at the end of December, for a total value of $85.83 million. It was the fund’s second largest holding. Goodyear was David Tepper’s second largest position at the end of the third quarter as well but the fund held a much larger stake then – 10.76 million shares valued at $108.59 million. Goodyear opened trading on February 15 at $13.28 a share on a one-year target estimate of $19.21 (range $15 to $22). Goodyear is priced super low relative to its future earnings, with a forward P/E of just 4.83. Carlisle Companies (CSL) is Goodyear’s closest competitor by market cap ($2.91B vs. Goodyear’s $3.20B). However, Goodyear looks to be the better bet. Carlisle opened at $47.73 a share on a one-year target estimate of $54.50 and is priced higher at 11.20 times its forward earnings.

Appaloosa Management’s third largest position at the end of the fourth quarter was in Apple (AAPL). The fund held 181,850 shares in the company, for a total value of $73.65 million. This represents a significant increase from Appaloosa’s holdings in the company at the end of the third quarter, when it had had just 38,119 shares, valued at $14.53 million. Appaloosa also held significant stakes in Dean Foods (DF), Macy’s (M), Microsoft (MSFT) and the International Paper (IP) at the end of the fourth quarter. Apple and Microsoft are two of the 5 most popular stocks among hedge fund managers for more than a year. Value investor David Einhorn’s top two positions are these two stocks. The reason is simple. These stocks are extremely undervalued, trading at around 7-8 times their forward earnings and they have huge amounts of cash on their balance sheets. They are also expected to grow their earnings between 10-20% annually. Now is the time to buy them.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!